image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Cape - Big upgrades to eps forecasts

April 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CIU
  • Price:
  • 248p
Cape's finals smashed expectations with pretax profit rising nearly 26% to £60.7m, well ahead of the £55m forecast. Eps was 37.5p (forecast: 34p). Net debt reduced by 31% to £113.6m, while Cape expects to reinstate dividends later this year.  UK operating profit fell 6% to £25.4m reflecting strong activity from offshore projects, but decline in onshore. The star performer was the Gulf / Middle East division, where profit rose 67% to £38.6m. Of the smaller regions, the CIS increased profits 5% to £6.1m while the Far East / Pacific Rim halved profits to £7.9m.The lack of headway in the shares may reflect Cape's unexpected full provision of £70.5m to cover all future asbestos liabilities, although analysts welcome ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X